home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences
Search  -  prev / next
 
 

Pregnant participants in clinical trials

 
  December 11, 2024  
     
 
Xtalks, Online
2025-01-17


Excluding pregnant and breastfeeding persons from clinical research has resulted in a significant deficiency of crucial dosing and safety data, leading to incomplete or non-existing information for healthcare professionals and patients at the time of drug approval. Women are entitled to explicit, evidence-based guidance to manage their diseases and chronic conditions during pregnancy and lactation, ensuring the best possible outcomes for both their health and that of their newborn.

Explanations on the ethical considerations supporting the inclusion of pregnant individuals in clinical research brought attention to the removal of the outdated classification of pregnant individuals as a vulnerable population. Several institutions and regulatory agencies have responded to recent developments with initiatives to enhance the participation of pregnant and lactating individuals in clinical studies.

This webinar will cover recent and ongoing efforts to increase the inclusion of pregnant and lactating individuals in clinical trials. The expert speakers will examine new guidance under development, existing and proposed guidances and the FDA’s PDUFA VII commitments to establish a framework for pregnancy safety studies.

Register for this webinar to explore how the inclusion of pregnant and lactating individuals in clinical trials is transforming healthcare outcomes.

Keywords: Drug Development, Pregnancy, Clinical Research, CRO, Clinical Data, Pediatric Drug Development, Pediatric Patients, Pediatric Trials, Pediatric Oncology, Pediatric Disease, Pediatric Rare Disease
 
 
Organized by: Xtalks
Invited Speakers: Dr. Martine Dehlinger-Kremer, PhD, MS, Vice President of Scientific Affairs, Pediatric Subject Matter Expert, Centre for Pediatric Clinical Development, Drug Development Solutions, ICON
Dr. Mark Sorrentino, MD, MS, Vice President, Centre for Pediatric Clinical Development, Drug Development Solutions, ICON
Dr. Monica Lee, MD, Medical Director, Medical Affairs, ICON
Ms. Heather Peterson, RN, BSN, Paediatric Strategy Liaison, Centre for Paediatric Clinical Development (CPCD), ICON
 
Deadline for Abstracts: 2025-01-17
 
Registration: Free Registration
E-mail: tristan@xtalks.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.